Answers are grounded in this paper and cite their sources.
This study demonstrates for the first time in elderly adults without heart disease that intervention with supplemental oxygen in the clinical range will ameliorate central apneas and hypopneas by decreasing the propensity to central apnea through decreased chemoreflex sensitivity, even in the absence of a reduction in the plant gain. Thus, the study provides physiological evidence for use of supplemental oxygen as therapy for mild-to-moderate SDB in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Rastogi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: